CYTK•benzinga•
B of A Securities Maintains Neutral on Cytokinetics, Lowers Price Target to $54
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 15, 2025 by benzinga